West Nile virus central nervous system infection in patients treated with rituximab: Implications for diagnosis and prognosis, with a review of literature Academic Article uri icon

Overview

MeSH Major

  • Anti-Bacterial Agents
  • Community-Acquired Infections
  • Drug Resistance, Bacterial
  • Guidelines as Topic
  • Pneumonia

abstract

  • The spectrum of West Nile virus (WNV) infection continues to be elucidated. Many cases of WNV are asymptomatic; however, in immunocompromised patients, symptoms are more likely to be severe. We describe fatal WNV central nervous system disease in lymphoma patients who received rituximab, blunting the inflammatory response and complicating diagnosis.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC4643542

Digital Object Identifier (DOI)

  • 10.1093/ofid/ofv136

PubMed ID

  • 26576450

Additional Document Info

start page

  • ofv136

volume

  • 2

number

  • 4